Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Receivables (2019 - 2025)

Pulmonx has reported Change in Receivables over the past 7 years, most recently at -$1.4 million for Q3 2025.

  • Quarterly Change in Receivables fell 492.76% to -$1.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Sep 2025, up 70.96% year-over-year, with the annual reading at $1.3 million for FY2024, 57.86% down from the prior year.
  • Change in Receivables was -$1.4 million for Q3 2025 at Pulmonx, down from $1.2 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $1.8 million in Q4 2023 and troughed at -$1.4 million in Q3 2025.
  • The 5-year median for Change in Receivables is $715000.0 (2023), against an average of $503421.1.
  • Year-over-year, Change in Receivables skyrocketed 793.41% in 2023 and then tumbled 492.76% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$387000.0 in 2021, then skyrocketed by 431.78% to $1.3 million in 2022, then surged by 37.23% to $1.8 million in 2023, then decreased by 1.19% to $1.7 million in 2024, then crashed by 180.99% to -$1.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Change in Receivables are -$1.4 million (Q3 2025), $1.2 million (Q2 2025), and $721000.0 (Q1 2025).